Literature DB >> 24670237

Neonatal outcome following new assisted reproductive technology regulations in Turkey - a nationwide multicenter point prevalence study.

Nilgun Kultursay1, Mehmet Yalaz, Ozge Altun Koroglu.   

Abstract

OBJECTIVE: In March 2010, a new legislation about assisted reproductive technology (ART) activities, favoring single embryo transfer, was introduced in Turkey. Consequences of new regulations on neonatal outcome have not been evaluated in multicenter studies yet. In this study, our aim was to evaluate neonatal outcome of infants from medically assisted reproduction (MAR) pregnancies in the post-legislation era.
METHODS: A point prevalence study was conducted at 51 centers in Turkey on 1 April 2013. Data about fertility treatments and neonatal characteristics were evaluated for "live births" (Group 1) and "patients being cared in the NICU" (Group 2).
RESULTS: Seventeen (4%) of 420 infants in group 1, and 89 (8.1%) of 1094 infants in group 2 were born after MAR pregnancies. The ratio of multiple births in MAR pregnancies was still very high as 47.1% for group 1, 69.1% for group 2 infants. MAR babies constituted 9.9% of infants in Level 3 NICUs and 7.6% infants in Level 2 NICUs. MAR was associated with increased risk of multiple births and prematurity.
CONCLUSIONS: After the new legislation, multiple birth rates are still high in MAR pregnancies, resulting in unfavorable neonatal outcomes. Efforts to decrease multiple birth rates should be encouraged.

Entities:  

Keywords:  Assisted reproductive technology; legislation; medically assisted reproduction; morbidity; multiple births; newborn

Mesh:

Year:  2014        PMID: 24670237     DOI: 10.3109/14767058.2014.908844

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  1 in total

1.  Fertility in Patients with Thalassemia and Outcome of Pregnancies: A Turkish Experience

Authors:  Burcu Akıncı; Akkız Şahin Yaşar; Nihal Özdemir Karadaş; Zuhal Önder Siviş; Hamiyet Hekimci Özdemir; Deniz Yılmaz Karapınar; Can Balkan; Kaan Kavaklı; Yeşim Aydınok
Journal:  Turk J Haematol       Date:  2019-06-14       Impact factor: 1.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.